Gadi Riesenfeld
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Gadi Riesenfeld was the founder of Otic Pharma Ltd., founded in 2008, serving as Chairman from 2011 to 2012.
The current job is Chairman & Chief Executive Officer at Timestamp Ltd. starting in 2017.
Former jobs include Independent Director at NurExone Biologic, Inc. from 2023 to 2026; President & Chief Operating Officer at W World Corp.
from 1992 to 2005; President at W World Corp.
from 1992 to 2006; President & Managing Director at Kamapharm Ltd. from 1990 to 1991; and President & Managing Director at Galisar Ltd. from 1986 to 1988.
Education includes a doctorate from The Hebrew University of Jerusalem.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 19-04-2025 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Timestamp Ltd. | Algemeen Directeur | 01-01-2017 |
| Bedrijven | Functie | Einde |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Directeur/Bestuurslid | 30-01-2026 |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Oprichter | 01-01-2012 |
| W WORL | President | 01-01-2006 |
| W WORL | President | 01-11-2005 |
Kamapharm Ltd. | Algemeen Directeur | 01-05-1991 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
W World Corp.
W World Corp. Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceutical products | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for ear indications | Health Technology |
Kamapharm Ltd. | |
Galisar Ltd. | |
Timestamp Ltd. | |
NurExone Biologic, Inc.
NurExone Biologic, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau